Search Results - "Molhoek, S G"

Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm by Kiès, P, Leclercq, C, Bleeker, G B, Crocq, C, Molhoek, S G, Poulain, C, van Erven, L, Bootsma, M, Zeppenfeld, K, van der Wall, E E, Daubert, J-C, Schalij, M J, Bax, J J

“…Objective: To evaluate the impact of long term cardiac resynchronisation therapy (CRT) on left atrial and left ventricular (LV) reverse remodelling and…”
Get full text

Atrial and brain natriuretic peptides as markers of response to resynchronisation therapy by Molhoek, S G, Bax, J J, van Erven, L, Bootsma, M, Steendijk, P, Lentjes, E, Boersma, E, van der Laarse, A, van der Wall, E E, Schalij, M J

“…Comparison of data was performed using the Student t test for paired and unpaired data when appropriate. Since BNP and ANP are not normally distributed, we…”
Get full text

Eligibility for biventricular pacing in patients with an implantable cardioverter defibrillator by Molhoek, S.G., Bax, J.J., van Erven, L., Steendijk, P., van der Wall, E.E., Schalij, M.J.

“…Implantable cardioverter defibrillator (ICD)‐therapy prevents sudden death in patients at high risk, but incidence of death due to heart failure remains…”
Get full text

Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy by Bax, Jeroen J., Bleeker, Gabe B., Marwick, Thomas H., Molhoek, Sander G., Boersma, Eric, Steendijk, Paul, van der Wall, Ernst E., Schalij, Martin J.

“…This study was designed to predict the response and prognosis after cardiac resynchronization therapy (CRT) in patients with end-stage heart failure (HF)…”
Get full text

Left ventricular dyssynchrony predicts benefit of cardiac resynchronization therapy in patients with end-stage heart failure before pacemaker implantation by Bax, Jeroen J., Marwick, Thomas H., Molhoek, Sander G., Bleeker, Gabe B., van Erven, Lieselot, Boersma, Eric, Steendijk, Paul, van der Wall, Ernst E., Schalij, Martin J.

“…We evaluated patients with end-stage heart failure who have a high likelihood of response to cardiac resynchronization therapy (biventricular pacing). It…”
Get full text

Myocardial tissue Doppler echocardiography and cardiac resynchronization therapy by Molhoek, S G, Schalij, M J, Van Der Wall, E E, Bax, J J

“…Cardiac resynchronization therapy (CRT) is a promising technique for patients with end-stage, drug-refractory heart failure. Still 20-30% of the patients…”
Get more information

Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization device by Borleffs, C. Jan Willem, van Bommel, Rutger J., Molhoek, Sander G., de Leeuw, Joost G., Schalij, Martin J., van Erven, Lieselot

“…Aims The aim of this study was to assess the requirement for coronary sinus (CS) lead intervention after cardiac resynchronization therapy (CRT) and to…”
Get full text

Relationship Between QRS Duration and Left Ventricular Dyssynchrony in Patients with End-Stage Heart Failure by BLEEKER, GABE B., SCHALIJ, MARTIN J., MOLHOEK, SANDER G., VERWEY, HARRIETTE F., HOLMAN, EDUARD R., BOERSMA, ERIC, STEENDIJK, PAUL, VAN DER WALL, ERNST E., BAX, JEROEN J.

“…Introduction: Patients with end‐stage heart failure and a wide QRS complex are considered candidates for cardiac resynchronization therapy (CRT). However, 20%…”
Get full text

Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation by Molhoek, Sander G., Bax, Jeroen J., Bleeker, Gabe B., Boersma, Eric, van Erven, L., Steendijk, Paul, van der Wall, Ernst E., Schalij, Martin J.

“…Cardiac resynchronization therapy (CRT) is a new therapeutic option for patients who have drug-refractory end-stage heart failure. Much information has been…”
Get full text

Past, present and future of ACE inhibitors: Vienna, 1 September 2007 by Molhoek, S. G.

Get full text

Incidence and Risk Factors of Early Venous Thrombosis Associated with Permanent Pacemaker Leads by VAN ROODEN, CORNELIS J., MOLHOEK, SANDER G., ROSENDAAL, FRITS R., SCHALIJ, MARTIN J., MEINDERS, A. EDO, HUISMAN, MENNO V.

“…Introduction: Pacemaker lead implantation can cause thrombosis, which can be associated with serious local morbidity and complicated by pulmonary embolism. Few…”
Get full text

Left Ventricular Dyssynchrony Predicts Right Ventricular Remodeling After Cardiac Resynchronization Therapy by Bleeker, Gabe B., Schalij, Martin J., Nihoyannopoulos, Petros, Steendijk, Paul, Molhoek, Sander G., van Erven, Lieselot, Bootsma, Marianne, Holman, Eduard R., van der Wall, Ernst E., Bax, Jeroen J.

“…Left Ventricular Dyssynchrony Predicts Right Ventricular Remodeling After Cardiac Resynchronization Therapy Gabe B. Bleeker, Martin J. Schalij, Petros…”
Get full text

Usefulness of myocardial tissue Doppler echocardiography to evaluate left ventricular dyssynchrony before and after biventricular pacing in patients with idiopathic dilated cardiomyopathy by Bax, Jeroen J., Molhoek, Sander G., van Erven, Lieselot, Voogd, Paul J., Somer, Soeresh, Boersma, Eric, Steendijk, Paul, Schalij, Martin J., Van der Wall, Ernst E.

“…Recently, simultaneous biventricular pacing has been proposed as an alternative treatment in patients with drug refractory heart failure. The clinical benefit…”
Get full text

QRS Duration and Shortening to Predict Clinical Response to Cardiac Resynchronization Therapy in Patients with End-Stage Heart Failure by MOLHOEK, SANDER G., BAX, JEROEN J., BOERSMA, ERIC, ERVEN, LIESELOT VAN, BOOTSMA, MARIANNE, STEENDIJK, PAUL, VAN DER WALL, ERNST E., SCHALIJ, MARTIN J.

“…Despite current selection criteria (NYHA Class III–IV, LVEF < 35%, QRS > 120 ms with LBBB), 30% of patients do not benefit from cardiac resynchronization…”
Get full text

Frequency of left ventricular dyssynchrony in patients with heart failure and a narrow QRS complex by Bleeker, Gabe B., Schalij, Martin J., Molhoek, Sander G., Holman, Eduard R., Verwey, Harriette F., Steendijk, Paul, van der Wall, Ernst E., Bax, Jeroen J.

“…Cardiac resynchronization therapy (CRT) is considered a major advance in the treatment of patients with heart failure. The presence of left ventricular (LV)…”
Get full text

Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy by Molhoek, Sander G, Bax, Jeroen J, van Erven, Lieselot, Bootsma, Marianne, Boersma, Eric, Steendijk, Paul, van der Wall, Ernst E, Schalij, Martin J

“…Cardiac resynchronization therapy (CRT) is a recently introduced therapeutic option for patients with severe heart failure and intraventricular conduction…”
Get full text

Comparison of Effectiveness of Cardiac Resynchronization Therapy in Patients <70 Versus ≥70 Years of Age by Bleeker, Gabe B., Schalij, Martin J., Molhoek, Sander G., Boersma, Eric, Steendijk, Paul, van Der Wall, Ernst E., Bax, Jeroen J.

“…In the present study, the effects of cardiac resynchronization therapy (CRT) in elderly patients were evaluated. The study included 170 consecutive patients…”
Get full text

Setting the standard in pulmonary hypertension management: Vienna, 4 September 2007 by Molhoek, S. G., Vliegen, H. W.

Get full text

17.5 Failure to respond to CRT is not caused by technical failures by van Erven, L., Molhoek, S. G., Bax, J. J., van der Wall, E. E., Schalij, M. J.

Get full text

18.1 High incidence of atrial fibrillation patients with resynchronization therapy: Does it affect outcome? by van Erven, L., Bax, J. J., Molhoek, S. G., van der Wall, E. E., Schalij, M. J.

Get full text